drugset / Trial / NCT01409408
Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan
RandomizedParallel-groupDouble-blindTreatment
Summary
Assess if aliskiren is capable of enhancing vascular stiffness and endothelial function and compare theses effects and renin activity and concentration to those obtained with a calcium channel blocker, amlodipine, in patients with diabetes mellitus type 2 and blood pressure not controlled by 100 mg per day of losartan.
Timeline
- Start
- 2011-04
- Primary completion
- 2013-04
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aliskiren | Small molecule | 300 mg | — |
| Comparator | Amlodipine | Other / unclassified | 5 mg | — |